About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) group arises from the merger of two VHIR groups, the Clinical Biochemistry group and the Drug Delivery and Targeting group, which they develop preclinical and clinical research in the diagnosis and therapy of different diseases.
With a direct link to the Clinical Biochemistry service of the Vall d'Hebron Hospital, our scope of action ranges from the analysis of massive data coming from the service, the development of diagnostic and prognostic biomarkers, evaluation of existing therapies and the development of new therapeutic strategies based on nanotechnology.
In terms of specific pathologies or indications, the group has an extensive track record in basic and applied research in cancer (new biomarkers, therapeutic targets and new treatments), metabolopathies (biomarkers and improvements in enzyme replacement therapy), kidney disease and liver disease.
PMID: 37963304 Journal: JOURNAL OF CLINICAL ONCOLOGY Year: 2023 Reference: J Clin Oncol. 2023 Nov 14:JCO2300339. doi: 10.1200/JCO.23.00339. Impact factor: Publication type: Paper in international publication Authors: Agarwal, Neeraj; Augustin, Salvador; Barnicle, Alan; Chi, Kim N; Ciudin, Andreea; de Bono, Johann S; Ferrer-Costa, Roser; Fizazi, Karim; Gabriel-Medina, Pablo; Hussain, Maha et al. DOI: 10.1200/JCO.23.00339
PMID: 37964360 Journal: BREAST CANCER RESEARCH Year: 2023 Reference: Breast Cancer Res. 2023 Nov 14;25(1):143. doi: 10.1186/s13058-023-01736-y. Impact factor: Publication type: Paper in international publication Authors: Baulida, Josep; Benitez-Carbante, Maria Isabel; Benitez-Carbante, Maria Isabel; Diaz de Heredia, Cristina; Eyras, Eduardo; Fernandez Ledesma, Berta; Fernandez Ledesma, Berta; Fernandez-Polo, Aurora; Franco-Valls, Hector; Garcia de Herreros, Antonio et al. DOI: 10.1186/s13058-023-01736-y
PMID: 37996255 Journal: ANNALS OF CLINICAL BIOCHEMISTRY Year: 2023 Reference: Ann Clin Biochem. 2023 Nov 23:45632231219387. doi: 10.1177/00045632231219387. Impact factor: Publication type: Paper in international publication Authors: Andrade, Monica Viegas; Blanco, Albert; Bracarense, Henrique; Braga, Paulo Estevao Franco; Comas, Immaculada; Conesa, Laura; de Miranda, Maria Carolina Correa; de Souza, Aline; Diaz-Troyano, Noelia; Ferrer, Roser et al. DOI: 10.1177/00045632231219387
PMID: 38000766 Journal: JOURNAL OF BIOMEDICAL INFORMATICS Year: 2023 Reference: J Biomed Inform. 2023 Nov 22:104553. doi: 10.1016/j.jbi.2023.104553. Impact factor: Publication type: Paper in international publication Authors: Amasi-Hartoonian, Nare; Ammour, Nadir; Begum, Amina; Blanco, Albert; Brown, Mollie; Comas, Immaculada; Conesa, Laura; Couvert, Camille; Diaz-Troyano, Noelia; Didden, Eva-Maria et al. DOI: 10.1016/j.jbi.2023.104553
PMID: 36581627 Journal: Scientific Reports Year: 2022 Reference: Sci Rep. 2022 Dec 29;12(1):22571. doi: 10.1038/s41598-022-24918-8. Impact factor: Publication type: Paper in international publication Authors: Adombi, Caroline Melanie; Andres, Cristina; Anton, Andres; Borras, Blanca; Campos, Carolina; Codina, Maria Gema; Colomer-Castell, Sergi; Esperalba, Juliana; Esteban, Juan Ignacio; Garcia-Cehic, Damir et al. DOI: 10.1038/s41598-022-24918-8
PMID: NOPMID0100 Journal: Advances in Laboratory Medicine Year: 2022 Reference: Adv Lab Med / Av en Med Lab. 2022;3(3):263-271. doi:10.1515/almed-2022-0016 Impact factor: Publication type: Paper in national publication Authors: Barquin Del Pino , Raquel ; Benitez Carabante, Maria Isabel ; Casis Saenz, Ernesto; Castellote Bellés, Laura; Ferrer Costa, Roser; López Hellin, Joan; Martinez Sánchez, Luisa; Miarons Font , Marta; Paciucci Barzanti, Rosanna; Rodríguez Frias, Francisco et al. DOI: 10.1515/almed-2022-0016
PMID: NOPMID0101 Journal: Ceramics International Year: 2022 Reference: Ceram Int. 2023;49(6):9324-9337. doi:10.1016/j.ceramint.2022.11.099 Impact factor: Publication type: Paper in international publication Authors: Abasolo, Ibane; Bomati-Miguel, Óscar; Felix, Eduardo; Fernández-Ponce, Cecilia; García-Cózar, Francisco; Kriwet, Jürgen; Lahoz, Ruth; Litrán, Rocío; Llaguno-Munive, Monserrat; Mánuel, Jose M et al. DOI: 10.1016/j.ceramint.2022.11.099
PMID: PMID0102 Journal: Rare Disease and Orphan Drugs Journal Year: 2022 Reference: Rare Dis Orphan Drugs J. 2022;1(3):13. doi:10.20517/rdodj.2022.09 Impact factor: Publication type: Editorail in international publication Authors: Abasolo, Ibane; Gazeau, Florence; K. A. Silva, Amanda; Sagné, Corinne et al. DOI: 10.20517/rdodj.2022.09
PMID: 33738082 Journal: Journal of Extracellular Vesicles Year: 2021 Reference: J Extracell Vesicles. 2021 Mar;10(5):e12058. doi: 10.1002/jev2.12058. Epub 2021 Mar 12. Impact factor: Publication type: Paper in international publication Authors: Abasolo, Ibane; Albertazzi, Lorenzo; Boullosa, Ana; Casas, Josefina; Corchero, Jose Luis; Diaz-Riascos, Zamira V; Garcia-Aranda, Natalia; Garcia-Fruitos, Elena; Gonzalez, Patricia; Grayston, Alba et al. DOI: 10.1002/jev2.12058
PMID: 33720484 Journal: JOURNAL OF VIRAL HEPATITIS Year: 2021 Reference: J Viral Hepat. 2021 Sep;28(9):1319-1324. doi: 10.1111/jvh.13497. Epub 2021 Mar 22. Impact factor: Publication type: Paper in international publication Authors: Buti, Maria; Campos, Carolina; Canizares, Angelina; Carrion, Jose Antonio; Castro-Iglesias, Angeles; Costa, Juan Garcia; Esteban, Juan Ignacio; Garcia-Cehic, Damir; Gregori, Josep; Macenlle, Ramiro et al. DOI: 10.1111/jvh.13497
PMID: 33669498 Journal: MOLECULES Year: 2021 Reference: Molecules. 2021 Feb 19;26(4). pii: molecules26041085. doi: 10.3390/molecules26041085. Impact factor: Publication type: Paper in international publication Authors: Galindo, Maria F; Garcia-Fernandez, Alba Estela; Garcia-Fernandez, Francisco Javier; Ikuta, Ichiro; Jordan, Joaquin; Nava, Eduardo; Solis Garcia Del Pozo, Julian et al. DOI: 10.3390/molecules26041085
PMID: 33623672 Journal: Clinical Kidney Journal Year: 2021 Reference: Clin Kidney J. 2020 Aug 11;14(2):482-491. doi: 10.1093/ckj/sfaa110. eCollection 2021 Feb. Impact factor: Publication type: Review in international publication Authors: Agraz, Irene; Ariceta, Gema; Garcia-Carro, Clara; Jacobs-Cacha, Conxita; Lopez-Hellin, Joan; Moreso, Francesc; Seron, Daniel; Soler, Maria Jose; Toapanta-Gaibor, Nestor; Vergara, Ander et al. DOI: 10.1093/ckj/sfaa110
Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.
Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.
Researchers from all over Europe gathered to kick off the SPM4.0 project, an innovative Marie Curie Skłodowska (MSCA-DN) doctoral network that promotes the development of autonomous Scanning Probe Microscopy with AI.
